藥物成份

共有 21098 個藥物成份

Choline Bitartrate contains not less than 99.0 percent and not more than 100.5 percent of C9H19NO7,calculated on the anhydrous basis.

關聯藥證數量
1

Choline Bitartrate contains not less than 99.0% and not more than 100.5% of C9H19NO7, calculated on the anhydrous basis.

關聯藥證數量
1

Choline fenofibrate

關聯藥證數量
1

Chondroitin Sulfate Sodium contains not less than 95.0% and not more than 105.0% of (C14H19NNa2O14S)x, calculated on dried substance.

關聯藥證數量
1

Chondroitin sulfate contains not less than 2.5% and not more than 3.8% of nitrogen and not less than 5.5% and not more than 7.5% of sulfur.

關聯藥證數量
1

Chromium (as Chromium Chloride )

關聯藥證數量
1

Chromium Chloride Hexahydrate

關聯藥證數量
1

Chromogen TMB solution (concentrated) : \n90% DMSO solution containing 0.6%\nTetramethylbenzidine (TMB)

關聯藥證數量
1

Chromogenic substrate chromogenic substrate N-α-Z-D-Arg-Gly-Arg-pNA 2HCl.\nFactor Xa reagent bovine Factor X2, heparin, bovine serum albumin.

關聯藥證數量
1

Chromogenic substrate: the lyophilized chromogenic substrate N-a-Z-D-Arg-Gly-Arg-pNA？2HCl, synthetic thrombin inhibitor and bulking agent(mannitol).\nFactor reagent: containing bovine factor IXa, factor X and thrombin lyophilized with CaCl2 and phospholipid.\nBuffer: TRIS Buffer, ionic strength 0.08 with Polybrene, NaCl and bovine serum albumin.

關聯藥證數量
1

Chromotrope 2R、Light greeen、Phosphotungstic acid、Acetic Acid, Glacial

關聯藥證數量
1

Ci-Trol 1 is produced from pooled, fresh citrated normal human plasma.

關聯藥證數量
1

Ci-Trol 2, 3 are produced from citrated human plasma.

關聯藥證數量
1

Ci-Trol Heparin Controls, Low and High: lyophilized preparations of citrated human plasma containing sodium heparin with buffer and stabilizers added.

關聯藥證數量
1

Ciclopirox Olamine contains not less than 76.0% and not more than 78.5% of C12H17NO2, and not less than 22.2% and not more than 23.3% of C2H7NO, calculated on the dried substance.

關聯藥證數量
1

Ciclopirox Olamine contains not less than 76.0% and not more than 78.5.0% of ciclopirox(C12H17NO2), and not less than 22.2% and not more than 23.3% of 2-aminoethanol (C2H7NO), calculated on dried substance.

關聯藥證數量
1

Ciclopirox Olamine contains not less than 97.5% and not more than 101.5% of C12H17NO2.C2H7NO.

關聯藥證數量
1

Cilastatin Sodium contains not less than 98.0 percent and not more than 101.5 percent of C16H25N2NaO5S, calculated on the anhydrous and solvent-free basis.

關聯藥證數量
1

Cilostazol It contains not less than 98.5% and not more than 101.5% of C20H27N5O2 calculated on the anhydrous substance.

關聯藥證數量
1

Cilostazol contains not less than 98.0% and not more than 102.0% of C20H27N5O2 calculated on the dried basis.

關聯藥證數量
1

Cilostazol contains not less than 98.0% and not more than 102.0% of C20H27N5O2, calculated on the dried basis.

關聯藥證數量
1

Cilostazol contains not less than 98.5% and not more than 101.5% of C20H27N5O2 calculated on the anhydrous substance.

關聯藥證數量
1

Cilostazol contains not less then 98.0% and not more then 102.0% of C20H27N5O2, calculated on the dried basis.

關聯藥證數量
1

Cimetidine contains 98.0%~102.0% of C10H16N6S, calculated on the dried basis.

關聯藥證數量
1

Cimetidine contains not less than 98% and not more than 102% of C10H16N6S, calculated on the dried basis.

關聯藥證數量
1

Cimetidine contains not less than 98.0 % and not more than 102.0 % of C10H16N6S, calculated on the dried basis.

關聯藥證數量
1

Cimetidine contains not less than 98.0 % and not more than 102.0% of C10H16N6S, calculated on the dried basis.

關聯藥證數量
1

Cimetidine contains not less than 98.0 percent and not more than 102.0 percent of C10H16N6S, calculated on the dried basis.

關聯藥證數量
1

Cimetidine contains not less than 98.0% and not more than 102.0% of C10H16N6S calculated on the dried basis.

關聯藥證數量
1

Cimetidine contains not less than 98.0% and not more than 102.0% of C10H16N6S, calculated on the dried basis.

關聯藥證數量
1

Cimetidine contains not less than 98.0% and not more than 102.0% of C10H16N6S, calculated on the dried basis.

關聯藥證數量
1

Cimetidine contains not less than 99.0% and not more than 101.5% of C10H16N6S，calculated on the dried basis.

關聯藥證數量
1

Cinchocaine Hydrochloride contains not less than 98.5% and not more than 101.0% of C20H30ClN3O2 calculated on the dried basis.

關聯藥證數量
1

Cinnarizine contains not less than 99.0% and not more than 101.0% of C26H28N2, calculated with reference to the dried substance.

關聯藥證數量
1

Ciprofloxacin 0.002-32 μg/mL, Gatifloacin 0.002-32 μg/mL, Levofloxacin 0.002-32 μg/mL, Moxifloxacin 0.002-32 μg/mL, Ofloxacin 0.002-32 μg/mL.

關聯藥證數量
1

Ciprofloxacin Hydrochloride contains NLT 98.0% and NMT 102.0% of C17H18FN3O3‧HCl, calculated on anhydrous substance.

關聯藥證數量
1

Ciprofloxacin Hydrochloride contains not less than 98% and not more than 102% of C17H18FN3O3？HCl, calculated on the anhydrous basis.

關聯藥證數量
1

Ciprofloxacin Hydrochloride contains not less than 98.0 percent and not more than 102.0 percent of C17H18FN3O3 HCl, calculated on the anhydrous.

關聯藥證數量
1

Ciprofloxacin Hydrochloride contains not less than 98.0 percent and not more than 102.0 percent of C17H18FN3O3.HCL, calculated on the anhydrous basis.

關聯藥證數量
1

Ciprofloxacin Hydrochloride contains not less than 98.0% and more than 102.0% of C17H18FN3O3？HCl, calculated on the anhydrous basis.

關聯藥證數量
1

Ciprofloxacin Hydrochloride contains not less than 98.0% and not more than 102.0% of C17H18FN3O3, HCl, calculated on the anhydrous basis.

關聯藥證數量
1

Ciprofloxacin Hydrochloride contains not less than 98.0% and not more than 102.0% of C17H18FN3O3.HCl, calculated on the anhydrous basis.

關聯藥證數量
1

Ciprofloxacin Hydrochloride contains not less than 98.0% and not more than 102.0% of C17H18FN3O3‧HCl, calculated on the anhydrous basis.

關聯藥證數量
1

Ciprofloxacin Hydrochloride contains not less than 98.0% and not more than 102.0% of C17H18FN3O3？HCl, calculated on the anhydrous basis.

關聯藥證數量
1

Ciprofloxacin Hydrochloride contains not less than 98.0% and not more than 102.0% of ciprofloxacin hydrochloride (C17H18FN3O3‧HCl), calculated on the anhydrous basis.

關聯藥證數量
1

Ciprofloxacin Hydrochloride：\nContains not less than 98.0% and not more than 102.0% of C17H18FN3O3. HCL, calculated on the anhydrous basis.

關聯藥證數量
1

Ciprofloxacin contains not less than 99.0% and not more than 101.0% of C17H18FN3O3, calculated on the dried substance.

關聯藥證數量
1

Ciprofloxacin, Levofloxacin, Norfloxacin, Ofloxacin

關聯藥證數量
1

Cis-Atracurium Besylate contains not less than 97.0% and not more than 101.0% of C65H82N2O18S2, calculated on anhydrous substance.

關聯藥證數量
1

Citalopram Hydrobromide Assay by potentiometry on dried basis (% W/W)：Not less than 99.0% and not more than 101.5%

關聯藥證數量
1

Citalopram Hydrobromide contains less than 98.0% and not more than 102.0% of C20H21FN2O, calculated on the anhydrous basis.

關聯藥證數量
1

Citalopram Hydrobromide contains not less than 98.0% and not more than 102.0% of C20H21FN2O‧HBr calculated on the anhydrous basis.

關聯藥證數量
1

Citalopram Hydrobromide contains not less than 98.5% and not more than 101.0% of C20H21FN2‧HBr, calculated on the anhydrous basis.

關聯藥證數量
1

Citric acid 25% (by weight)

關聯藥證數量
1

Clarithromycin contains not less than 96.0 % and not more than 102.0 % of C38H69NO13, calculated on the anhydrous basis.

關聯藥證數量
1

Clarithromycin contains not less than 96.0% and not more than 102.0% of C38H69NO13, calculated on the anhydrous basis.

關聯藥證數量
1

Clarithromycin contains the equivalent of less than 96.0% and not more than 102.0% of C38H69NO13, per mg, calculated on the anhydrous basis.

關聯藥證數量
1

Clavulanic acid contains not less than 17.4% of C5H9NO5, calculated with reference to the anhydrous basis.

關聯藥證數量
1

Clearview EASY HCG tests each containing murine monoclonal antibodies to hCG and goat antibodies.

關聯藥證數量
1

Clin Chem Control 1 and 2 lyophilized level 6x5 mL\nClin chem Cntrol 1 and 2 contains analytes in human serum matrix. Value and assigned range are indicated in the assigned concentrations table.

關聯藥證數量
1

Clindamycin 2mg/disc

關聯藥證數量
1

Clindamycin HCl contains NLT 800ug/mg of (C18H33ClN2O5S), calculated on the anhydrous basis.

關聯藥證數量
1

Clindamycin Hydrochloride Assay (on anhydrous basis): Not less than 800μg/mg

關聯藥證數量
1

Clindamycin Hydrochloride contains NLT 800 μg/ mg of C18H33CIN2O5S, calculated on dried basis.

關聯藥證數量
1

Clindamycin Hydrochloride contains not less than 92.0% and not more than 102.0% of C18H34Cl2N2O5, calculated on the dried basis.

關聯藥證數量
1

Clindamycin Hydrochloride has a potency equivalent to not less than 758 μg of clindamycin per mg, calculated on the anhydrous.

關聯藥證數量
1

Clindamycin Hydrochloride is the hydrated hydrochloride salt of clindamycin, a substance producd by the chlorinatioon of lincomycin. It has a potency equivalent to not less than 800ug of clindamycin (C18H33ClN2O5S) per mg.

關聯藥證數量
1

Clindamycin Hydrochloride is the hydrated hydrochloride salt of clindamycin, a substance produced by the chlorination of lincomycin. It has a potency equivalent to NLT 800 μg/mg of C18H33ClN2O5S

關聯藥證數量
1

Clindamycin Hydrochloride is the hydrated hydrochloride salt of clindamycin, a substance produced by the chlorination of lincomycin. It has a potency equivalent to NLT 800 μg/mg of C18H33ClN2O5S.

關聯藥證數量
1

Clindamycin Hydrochloride monohydrate Content：The content of Clindamycin should be not less than 800 μg/mg.

關聯藥證數量
1

Clindamycin Phosphate Content：NLT 758µg/mg of C18H33ClN2O5S (on anhydrous basis)

關聯藥證數量
1

Clindamycin Phosphate (Clindamycin Phosphate has a potency equivalent to not less than 758 μg/mg of clindamycin (C18H33ClN2O5S), calculated on the anhydrous basis.)

關聯藥證數量
1

Clindamycin Phosphate contains not less than 96.0% and not more than 102.0% of C18H34ClN2O8PS, calculated on the dried basis

關聯藥證數量
1

Clindamycin Phosphate has a potency equivalent to NLT 758 ug/mg of clindamycin (C18H33ClN2O5S), calculated on the anhydrous basis.

關聯藥證數量
1

Clindamycin Phosphate has a potency equivalent to not less than 758 ug of clindamycin (C18H33ClN2O5S) per mg, calculated on the anhydrous basis.

關聯藥證數量
1

Clindamycin Phosphate has a potency equivalent to not less than 758 ug of clindamycin per mg, calculated on the anhydrous.

關聯藥證數量
1

Clindamycin Phosphate\n(Clindamycin Phosphate has a potency equivalent to not less than 758 ug of clindamycin (C18H33CIN2O5S) per mg, calculated on the anhydrous basis.)

關聯藥證數量
1

Clinimate ALB: bromcresol green 0.18mmol/L、\n succinate buffer 76mmol/L\nAnaserum ALB TP Standard: Bovin Serum Albumin 60mg/mL

關聯藥證數量
1

Clinimate CA(1): monoethanolamine. \nClinimate CA(2): acetate buffer, o-cresolphthalein complexone (OCPC), 8-hydroxyqunoline-5-sulfonic acid.\nAnaserum CA Standard Solution:\nCalcium carbonate; Trichloroacetic acid.

關聯藥證數量
1

Clinimate CRE 1：sodium hydroxide 0.2 mol/L\n detergent\nClinimate CRE 2：2,4,6-trinitrophenol 28.4 mmol/L\nAnaserum CRE Standard Solution：Creatinint 0.1 mg/mL

關聯藥證數量
1

Clinimate D-BIL-2 j: glycine buffer (pH2.3) 30 mmol/L\nClinimate BIL？D-BIL-2 Sulfanilic Acid Solutionk: Sulfanilic acid 12 mmol/L; Hydrocholoric acid\nClinimate BIL？D-BIL-2 Reaction Reagentk: sodium nitrite 15mg/vial for 50mL

關聯藥證數量
1

Clinimate IP 1：p-methylaminophenol sulfate 10 mmol/L nonionic surfactantClinimate IP 2：ammonium molybdate 2.7 mmol/L sulfuric acid 0.6 mol/LAnaserum IP Standard：Potassium Dihydrogenphosphate 0.2 mg/mL of P Sodium Azide less than 0.1%

關聯藥證數量
1

Clinimate TP Cupric sulfate sulfate pentahydrate 6mmol/L, sodium hydroxide and surfactant

關聯藥證數量
1

Clinitek Atlas 10 Reagent Pak for Urine Chemistry：Protein: 0.3% tetrabromphenol blue; 97.3% buffer; 2.4% nonreactive ingredientsBlood: 6.8% diisopropylbenzene dihydroperoxide; 4.0% 3,3’,5,5’- tetramethylbenzidine; 48.0% buffer; 41.2% nonreactive ingredientsLeukocyte: 0.4% derivatized pyrrole amino acid ester, 0.2% diazonium salt; 40.9% buffer; 58.5% nonreactive ingredientsNitrite: 1.4% p-arsanilic acid; 1.3% 1,2,3,4-tetrahydro-benzo(h)- quinolin-3-ol; 10.8% buffer; 86.5% nonreactive ingredientsGlucose: 3.8% glucose oxidase (bacterial); 0.3% peroxidase (horseradish); 19.2% 4-aminoantipyrine; 11.7% 4-methylcatechol; 26.2% buffer; 38.8% nonreactive ingredientsKetone: 7.1% sodium nitroprusside; 92.9% bufferpH: 0.2% methyl red; 2.8% bromthymol blue; 97.0% nonreactive ingredientsBilirubin: 0.4% 2,4-dichloroaniline diazonium salt; 37.3% buffer; 62.3% nonreactive ingredientsUrobilinogen: 0.2% p-diethyaminobenzaldehyde; 99.8% nonreactive ingredients

關聯藥證數量
1

Clioquinol contains not less than 98% and not more than 102% of C9H5ClINO, calculated on the dried basis.

關聯藥證數量
1

Clipizide contains not less than 98.0% and not more than the equivalent of 102.0% of C21H27N5O4S,calculated with reference to the dried substance.

關聯藥證數量
1

Clobetasol Propionate contains not less than 97.0 percent and not more than 102.0 percent of C25H32ClFO5, calculated on the dried basis.

關聯藥證數量
1

Clobetasol Propionate contains not less than 97.0 percent and not more than the equivalent of 102.0 percent of C25H32ClFO5 calculated on the dried basis.

關聯藥證數量
1

Clobetasol Propionate contains not less than 97.0% and not more than 102.0% of C25H32ClFO5, calculated on the dried basis.

關聯藥證數量
1

Clobetasol Propionate contains not less than 97.0% and not more than 102.0% of C25H32ClFO5, calculated with reference to the dried substance.

關聯藥證數量
1

Clobetasone Butyrate contains not less than 97.0 % and not more than 102.0 % of C26H32ClFO5, calculated on the dried substance.

關聯藥證數量
1

Clobetasone Butyrate contains not less than 97.0% and not more than 102.0% of C26H32ClFO5, calculated on the dried basis.

關聯藥證數量
1

Clobetasone Butyrate contains not less than 97.0% and not more than 102.0% of C26H32ClFO5, calculated with dried substance.

關聯藥證數量
1

Clodronate Disodium Tetrahydrate contains not less than 99.0% and not more than 101.0% of CH2Cl2Na2O6P2‧4H2O, calculated on anhydrous substance.

關聯藥證數量
1

Clonazepam contains 99.0% w/w to 101.0% w/w of C15H10N3O3Cl, calculated on anhydrous substance.

關聯藥證數量
1

Clonazepam contains not less than 99.0% and not more than 101.0% of C15H10ClN3O3 calculated on the dried substance.

關聯藥證數量
1

Clone My10: The monoclonal antibody is supplied as 100 ug purified immunoglobulin in 2.0 mL (50 ug/mL) of phosphate-buffered saline (PBS).Clone 8G12: The monoclonal antibody is supplied as 50 ug purified immunoglobulin in 2.0 mL(25 ug/mL) of PBS. The FITC and PE conjugates are each supplied as 50 ug in 2.0 mL (25 ug/mL) of PBS. The PerCP conjugate is supplied as 50 ug in 1.0 mL (50 ug/mL) of PBS. The PerCP-Cy5.5 conjugate is supplied as 12.5 ug in 1.0 mL (12.5 ug/mL) of PBS. The PE-Cy7 conjugate is supplied as 25 ug in 0.5 mL (50 ug/mL) of PBS. The APC conjugate is supplied as 50 ug in 0.5 mL (100 ug/mL) of PBS. PBS contains gelatin and 0.1% sodium azide. Twenty microliters (20 uL) of the monoclonal antibody, the FITC-, PE-, PerCP, or the PerCP-Cy5.5–conjugated antibody stains 106 peripheral blood mononuclear cells (PBMCs). Five microliters (5 uL) of the PE-Cy7– or the APC-conjugated antibody stains 106 PBMCs.

關聯藥證數量
1

Clone: SFC121Thy2D3; Hybridoma: NS/1-AG4 x BALB/c; Ig Chain: IgG1; Source: Conditioned medium; Conjugation: FITC (Fluorescein isothiocyanate); T8-FITC (lyophilized): The final concentration of nonantibody reagents when reconstituted to 500 μl is 0.2% gelatin, 0.01 M potassium phosphate, 0.15 M NaCl, and 0.1% NaN3.\n\n

關聯藥證數量
1

Clone: SFC121Thy2D3; Hybridoma: NS/1-AG4 x BALB/c; Ig Chain: IgG1; Source: Conditioned medium; Conjugation: RD1 (Phycoerythrin); T8-RD1: The concentration of nonantibody reagents in 0.5 ml (1 vial) is 0.2% BSA, 0.01 M potassium phosphate, 0.15 M NaCl, 0.1% NaN3, and stabilizers.

關聯藥證數量
1

Clophedianol HCl contains not less than 98.5% and not more than 101.5% of C17H20ClNO. HCl, calculated with reference to the dried substance.

關聯藥證數量
1